Correction to: Revefenacin: First Global Approval

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1179-1950
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Correction to: Revefenacin: First Global Approval ; day:29 ; month:3 ; year:2019 ; pages:1
Drugs ; (29.3.2019), 1

Urheber
Heo, Young-A
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s40265-019-01106-z
URN
urn:nbn:de:101:1-2019042022364474393492
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 11:03 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Heo, Young-A
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Correction to: Elagolix: First Global Approval

Correction to: Elagolix: First Global Approval

Correction to: Ivosidenib: First Global Approval

Correction to: Ivosidenib: First Global Approval

Correction to: Sarecycline: First Global Approval

Correction to: Sarecycline: First Global Approval

Correction to: Fremanezumab: First Global Approval

Correction to: Fremanezumab: First Global Approval

Correction to: Delafloxacin: First Global Approval

Correction to: Delafloxacin: First Global Approval

Correction to: Caplacizumab: First Global Approval

Correction to: Caplacizumab: First Global Approval

Correction to: Ibalizumab: First Global Approval

Correction to: Ibalizumab: First Global Approval

Correction to: Moxetumomab Pasudotox: First Global Approval

Correction to: Moxetumomab Pasudotox: First Global Approval

Correction to: Polatuzumab Vedotin: First Global Approval

Correction to: Polatuzumab Vedotin: First Global Approval

Correction to: Andexanet Alfa: First Global Approval

Correction to: Andexanet Alfa: First Global Approval

Correction to: Lonafarnib: First Approval

Correction to: Lonafarnib: First Approval

Correction to: Pexidartinib: First Approval

Correction to: Pexidartinib: First Approval

Verbundene Objekte